Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(1 site)
China
Tongji Hospital of Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei